DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $649,030 | -5.8% | 2,616 | -8.9% | 0.22% | -7.2% |
| Q2 2023 | $689,040 | -1.9% | 2,871 | +3.1% | 0.24% | -2.5% |
| Q1 2023 | $702,183 | -13.7% | 2,786 | -9.1% | 0.24% | -20.1% |
| Q4 2022 | $813,778 | -5.0% | 3,066 | -10.0% | 0.30% | -15.4% |
| Q3 2022 | $857,000 | -4.8% | 3,406 | -4.0% | 0.36% | +4.1% |
| Q2 2022 | $900,000 | -14.7% | 3,549 | -1.4% | 0.34% | +5.8% |
| Q1 2022 | $1,055,000 | +4.6% | 3,598 | +2.4% | 0.32% | +5.5% |
| Q4 2021 | $1,009,000 | +11.9% | 3,513 | +16.7% | 0.31% | +4.4% |
| Q3 2021 | $902,000 | -15.3% | 3,010 | -24.2% | 0.30% | -16.4% |
| Q2 2021 | $1,065,000 | +18.7% | 3,970 | -0.4% | 0.35% | +0.3% |
| Q1 2021 | $897,000 | +8.1% | 3,985 | +6.7% | 0.35% | +7.0% |
| Q4 2020 | $830,000 | +14.8% | 3,735 | +16.7% | 0.33% | -4.4% |
| Q3 2020 | $723,000 | -10.9% | 3,200 | -27.5% | 0.34% | -8.3% |
| Q2 2020 | $811,000 | -4.4% | 4,415 | -18.5% | 0.38% | -20.2% |
| Q1 2020 | $848,000 | -6.5% | 5,415 | -8.3% | 0.47% | +9.0% |
| Q4 2019 | $907,000 | -3.5% | 5,907 | -9.2% | 0.43% | -7.1% |
| Q3 2019 | $940,000 | -12.2% | 6,505 | -13.3% | 0.46% | -18.7% |
| Q2 2019 | $1,071,000 | +5.3% | 7,500 | -2.7% | 0.57% | +1.4% |
| Q1 2019 | $1,017,000 | +110.6% | 7,708 | +64.5% | 0.56% | +84.6% |
| Q4 2018 | $483,000 | +0.4% | 4,685 | +5.6% | 0.30% | +26.6% |
| Q3 2018 | $481,000 | +10.1% | 4,435 | 0.0% | 0.24% | -4.4% |
| Q2 2018 | $437,000 | -9.5% | 4,435 | -10.1% | 0.25% | -10.0% |
| Q1 2018 | $483,000 | +40.4% | 4,935 | +33.0% | 0.28% | +42.9% |
| Q4 2017 | $344,000 | +8.2% | 3,710 | 0.0% | 0.20% | +3.7% |
| Q3 2017 | $318,000 | -7.0% | 3,710 | -8.6% | 0.19% | -13.7% |
| Q2 2017 | $342,000 | -99.9% | 4,060 | +1.2% | 0.22% | +2.8% |
| Q1 2017 | $342,975,000 | +5.3% | 4,010 | -4.2% | 0.21% | +0.9% |
| Q4 2016 | $325,760,000 | +4.3% | 4,185 | +5.0% | 0.21% | 0.0% |
| Q3 2016 | $312,384,000 | -22.1% | 3,985 | +0.4% | 0.21% | -19.2% |
| Q2 2016 | $401,071,000 | -0.4% | 3,971 | -6.5% | 0.26% | -12.1% |
| Q1 2016 | $402,775,000 | +102127.2% | 4,246 | 0.0% | 0.30% | +14.2% |
| Q4 2015 | $394,000 | – | 4,246 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |